Rapport Therapeutics, Inc. (RAPP)

35.21 -0.63 (-1.76%) USD  |  NASDAQ  |  Jun 10, 16:00
35.21 0.00 (0.00%) Pre-Market: 08:39
More

Rapport Therapeutics EPS Diluted (TTM) : -2.603 for March 31, 2026

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for RAPP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical EPS Diluted (TTM) Data

View and export this data back to 2023. Start Trial.
Date Value
March 31, 2026 -2.603
December 31, 2025 -2.865
September 30, 2025 -2.692
June 30, 2025 -2.462
March 31, 2025 -2.203
December 31, 2024 -2.141
September 30, 2024 -1.964
Date Value
June 30, 2024 -1.723
March 31, 2024 -1.403
December 31, 2023 -0.9511
September 30, 2023 -0.5815
June 30, 2023 -0.3434
March 31, 2023 -0.1681

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
EyePoint, Inc. -3.502
Biofrontera, Inc. -1.109
ANI Pharmaceuticals, Inc. 3.942
Corcept Therapeutics, Inc. 0.35
Assertio Holdings, Inc. -5.733